⌘K

Home/Filings/4/0001213900-24-008459

4//SEC Filing

Shah Vinay 4

Accession 0001213900-24-008459

CIK 0001708331other

View on SEC.gov Company Profile

Filed

Jan 30, 7:00 PM ET

Accepted

Jan 31, 4:25 PM ET

Size

11.7 KB

Accession

0001213900-24-008459

Insider Transaction Report

Form 4

Period: 2024-01-29

Virpax Pharmaceuticals, Inc.VRPX

Chief Financial Officer

Transactions

Award
Stock Option (right to buy)
2024-01-29+112,000→ 112,000 total
Exercise: $0.32Exp: 2034-01-28→ Common Stock (112,000 underlying)

Footnotes (1)

[F1]These options vest pro rata on a monthly basis for 36 months commencing one year after the date of grant.

Documents

2 files

Issuer

Virpax Pharmaceuticals, Inc.

CIK 0001708331

Entity typeother

Related Parties

1

filerCIK 0001753078

Filing Metadata

Form type: 4
Filed: Jan 30, 7:00 PM ET
Accepted: Jan 31, 4:25 PM ET
Size: 11.7 KB

View on SEC.gov